Kew, J. N. C.; Kemp, J. A. Ionotropic and Metabotropic Glutamate Receptor Structure and Pharmacology. Psychopharmacol. 2005, 179, 4-29, 10.1007/s00213-005-2200-z
Traynelis, S. F.; Wollmuth, L. P.; McBain, C. J.; Menniti, F. S.; Vance, K. M.; Ogden, K. K.; Hansen, K. B.; Yuan, H.; Myers, S. J.; Dingledine, R. Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacol. Rev. 2010, 62, 405-496, 10.1124/pr.109.002451
Bassani, S.; Valnegri, P.; Beretta, F.; Passafaro, M. The GLUR2 Subunit of AMPA Receptors: Synaptic Role. Neuroscience 2009, 158, 55-61, 10.1016/j.neuroscience.2008.10.007
Bettler, B.; Mulle, C. Review: Neurotransmitter Receptors II. AMPA and Kainate Receptors. Neuropharmacology 1995, 34, 123-139, 10.1016/0028-3908(94)00141-E
Kumar, J.; Mayer, M. L. Functional Insights from Glutamate Receptor Ion Channel Structures. Annu. Rev. Physiol. 2013, 75, 313-337, 10.1146/annurev-physiol-030212-183711
Carlson, G. C. Glutamate Receptor Dysfunction and Drug Targets Across Models of Autism Spectrum Disorders. Pharmacol., Biochem. Behav. 2012, 100, 850-854, 10.1016/j.pbb.2011.02.003
Chang, P. K. Y.; Verbich, D.; McKinney, R. A. AMPA Receptors as Drug Targets in Neurological Disease-Advantages, Caveats, and Future Outlook. Eur. J. Neurosci 2012, 35, 1908-1916, 10.1111/j.1460-9568.2012.08165.x
Henley, J. M.; Wilkinson, K. A. Synaptic AMPA Receptor Composition in Development, Plasticity and Disease. Nat. Rev. Neurosci. 2016, 17, 337-350, 10.1038/nrn.2016.37
Kristensen, B. W.; Noraberg, J.; Zimmer, J. Comparison of Excitotoxic Profiles of ATPA, AMPA, KA and NMDA in Organotypic Hippocampal Slice Cultures. Brain Res. 2001, 917, 21-44, 10.1016/S0006-8993(01)02900-6
Sobolevsky, A. I. Structure and Gating of Tetrameric Glutamate Receptors. J. Physiol. 2015, 593, 29-38, 10.1113/jphysiol.2013.264911
Greger, I. H.; Esteban, J. A. AMPA Receptor Biogenesis and Trafficking. Curr. Opin. Neurobiol. 2007, 17, 289-297, 10.1016/j.conb.2007.04.007
Herguedas, B.; García-Nafría, J.; Cais, O.; Fernández-Leiro, R.; Krieger, J.; Ho, H.; Greger, I. H. Structure and Organization of Heteromeric AMPA-type Glutamate Receptors. Science 2016, 352, 549-559, 10.1126/science.aad3873
Greger, I. H.; Watson, J. F.; Cull-Candy, S. G. Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins. Neuron 2017, 94, 713-730, 10.1016/j.neuron.2017.04.009
Sobolevsky, A. I.; Rosconi, M. P.; Gouaux, E. X-ray Structure, Symmetry and Mechanism of an AMPA-subtype Glutamate Receptor. Nature 2009, 462, 745-756, 10.1038/nature08624
Weeks, A. M.; Harms, J. E.; Partin, K. M.; Benveniste, M. Functional Insight into Development of Positive Allosteric Modulators of AMPA Receptors. Neuropharmacology 2014, 85, 57-66, 10.1016/j.neuropharm.2014.05.022
Jin, R.; Clark, S.; Weeks, A. M.; Dudman, J. T.; Gouaux, E.; Partin, K. M. Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors. J. Neurosci. 2005, 25, 9027-9036, 10.1523/JNEUROSCI.2567-05.2005
Meyerson, J. R.; Kumar, J.; Chittori, S.; Rao, P.; Pierson, J.; Bartesaghi, A.; Mayer, M. L.; Subramaniam, S. Structural Mechanism of Glutamate Receptor Activation and Desensitization. Nature 2014, 514, 328-334, 10.1038/nature13603
Ptak, C. P.; Ahmed, A. H.; Oswald, R. E. Probing the Allosteric Modulator Binding Site of GluR2 with Thiazide Derivatives. Biochemistry 2009, 48, 8594-8602, 10.1021/bi901127s
Ptak, C. P.; Hsieh, C.-L.; Weiland, G. A.; Oswald, R. E. Role of Stoichiometry in the Dimer-stabilizing Effect of AMPA Receptor Allosteric Modulators. ACS Chem. Biol. 2014, 9, 128-133, 10.1021/cb4007166
Pirotte, B.; Francotte, P.; Goffin, E.; de Tullio, P. AMPA Receptor Positive Allosteric Modulators: a Patent Review. Expert Opin. Ther. Pat. 2013, 2, 615-628, 10.1517/13543776.2013.770840
Schvartz, N.; Torosdag, S.; Fertig, H.; Fletcher, L., Jr; Quan, R. B.; Schwartz, M. S.; Bryant, J. M. Cyclothiazide, a New Diuretic-antihypertensive Drug. Curr. Ther. Res. Clin. Exp. 1962, 4, 437-440
Bertolino, M.; Baraldi, M.; Parenti, C.; Braghiroli, D.; DiBella, M.; Vicini, S.; Costa, E. Modulation of AMPA/kainate Receptors by Analogues of Diazoxide and Cyclothiazide in Thin Slices of Rat Hippocampus. Receptors Channels 1993, 1, 267-278
Zivkovic, I.; Thompson, D. M.; Bertolino, M.; Uzunov, D.; DiBella, M.; Costa, E.; Guidotti, A. 7-Chloro-3-methyl-3-4-dihydro-2 H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a Benzothiadiazine Derivative that Enhances Cognition by Attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) Receptor Desensitization. J. Pharmacol. Exp. Ther. 1995, 272, 300-309
Thompson, D. M.; Guidotti, A.; DiBella, M.; Costa, E. 7-Chloro-3-methyl-3,4-dihydro-2 H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a Congener of Aniracetam, Potently Abates Pharmacologically Induced Cognitive Impairments in Patas Monkeys. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 7667-7671, 10.1073/pnas.92.17.7667
Pirotte, B.; Francotte, P.; Goffin, E.; Fraikin, P.; Danober, L.; Lesur, B.; Botez, I.; Caignard, D. H.; Lestage, P.; de Tullio, P. Ring-fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor Potentiators. Curr. Med. Chem. 2010, 17, 3575-3582, 10.2174/092986710792927859
Goffin, E.; Drapier, T.; Probst Larsen, A.; Geubelle, P.; Ptak, C. P.; Laulumaa, S.; Rovinskaja, K.; Gilissen, J.; de Tullio, P.; Olsen, L.; Frydenvang, K.; Pirotte, B.; Hanson, J.; Oswald, R. E.; Kastrup, S. J.; Francotte, P. 7-Phenoxy-Substituted 3,4-Dihydro-2 H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency. J. Med. Chem. 2018, 61, 251-264, 10.1021/acs.jmedchem.7b01323
Kaae, B. H.; Harpsøe, K.; Kastrup, J. S.; Sanz, A. C.; Pickering, D. S.; Metzler, B.; Clausen, R. P.; Gajhede, M.; Sauerberg, P.; Liljefors, T.; madsen, U. Structural Proof of a Dimeric Positive Modulator Bridging Two Identical AMPA Receptor-Binding Sites. Chem. Biol. 2007, 14, 1294-1303, 10.1016/j.chembiol.2007.10.012
Krintel, C.; Frydenvang, K.; Olsen, L.; Kristensen, M. T.; de Barrios, O.; Naur, P.; Francotte, P.; Pirotte, B.; Gajhede, M.; Kastrup, J. S. Thermodynamics and Structural Analysis of Positive Allosteric Modulation of the Ionotropic Glutamate Receptor GluA2. Biochem. J. 2012, 441, 173-178, 10.1042/BJ20111221
Nørholm, A.-B.; Francotte, P.; Olsen, L.; Krintel, C.; Frydenvang, K.; Goffin, E.; Challal, S.; Danober, L.; Botez-Pop, I.; Lestage, P.; Pirotte, B.; Kastrup, J. S. Synthesis, Pharmacological and Structural Characterization, and Thermodynamic Aspects of GluA2-Positive Allosteric Modulators with a 3,4-Dihydro-2 H-1,2,4-benzothiadiazine 1,1-Dioxide Scaffold. J. Med. Chem. 2013, 56, 8736-8745, 10.1021/jm4012092
Francotte, P.; Nørholm, A. B.; Deva, T.; Olsen, L.; Frydenvang, K.; Goffin, E.; Fraikin, P.; de Tullio, P.; Challal, S.; Thomas, J.-Y.; Iop, F.; Louis, C.; Botez-Pop, I.; Lestage, P.; Danober, L.; Kastrup, J. S.; Pirotte, B. Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2 H-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-substituted 4-Cyclopropyl-3,4-dihydro-2 H-1,2,4-benzothiadiazine 1,1-Dioxides. J. Med. Chem. 2014, 57, 9539-9553, 10.1021/jm501268r
Nørholm, A. B.; Francotte, P.; Goffin, E.; Botez, I.; Danober, L.; Lestage, P.; Pirotte, B.; Kastrup, J. S.; Olsen, L.; Oostenbrink, C. Thermodynamic Characterization of New Positive Allosteric Modulators Binding to the Glutamate Receptor A2 Ligand-binding Domain: Combining Experimental and Computational Methods Unravels Differences in Driving Forces. J. Chem. Inf. Model. 2014, 54, 3404-3416, 10.1021/ci500559b
Larsen, A. P.; Francotte, P.; Frydenvang, K.; Tapken, D.; Goffin, E.; Fraikin, P.; Caignard, D. H.; Lestage, P.; Danober, L.; Pirotte, B.; Kastrup, J. S. Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2 H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors. ACS Chem. Neurosci. 2016, 7, 378-390, 10.1021/acschemneuro.5b00318
Krintel, C.; Francotte, P.; Pickering, D. S.; JuknaiteÌ, L.; Pøhlsgaard, J.; Olsen, L.; Frydenvang, K.; Goffin, E.; Pirotte, B.; Kastrup, J. S. Enthalpy-Entropy Compensation in the Binding of Modulators at Ionotropic Glutamate Receptor GluA2. Biophys. J. 2016, 110, 2397-2406, 10.1016/j.bpj.2016.04.032
Francotte, P.; de Tullio, P.; Goffin, E.; Dintilhac, G.; Graindorge, E.; Fraikin, P.; Lestage, P.; Danober, L.; Thomas, J.-Y.; Caignard, D.-H.; Pirotte, B. Design, Synthesis, and Pharmacology of Novel 7-Substituted 3,4-Dihydro-2 H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of AMPA Receptors. J. Med. Chem. 2007, 50, 3153-3157, 10.1021/jm070120i
Girard, Y.; Atkinson, J. G.; Rokach, J. A New Synthesis of 1,2,4-Benzothiadiazines and a Selective Preparation of o-Aminobenzenesulphonamides. J. Chem. Soc., Perkin Trans. 1 1979, 1, 1043-1047, 10.1039/p19790001043
Meerwein, H.; Dittmar, G.; Göllner, R.; Hafner, K.; Mensch, F.; Steinfort, O. Untersuchungen über aromatische Diazoverbindungen, II. Verfahren zur Herstellung Aromatischer Sulfonsäurechloride, Eine Neue Modifikation der Sandmeyerschen Reaktion. Chem. Ber. 1957, 90, 841-852, 10.1002/cber.19570900602
Varney, M. A.; Rao, S. P.; Jachec, C.; Deal, C.; Hess, S. D.; Daggett, L. P.; Lin, F.-F.; Johnson, E. C.; Veliçelebi, G. Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells. J. Pharmacol. Exp. Ther. 1998, 285, 358-370
Weiss, J. N. The Hill Equation Revisited: Uses and Misuses. FASEB J. 1997, 11, 835-841, 10.1096/fasebj.11.11.9285481
Priel, A.; Selak, S.; Lerma, J.; Stern-Bach, Y. Block of Kainate Receptor Desensitization Uncovers a Key Trafficking Checkpoint. Neuron 2006, 52, 1037-1046, 10.1016/j.neuron.2006.12.006
Weston, M. C.; Schuck, P.; Ghosal, A.; Rosenmund, C.; Mayer, M. L. Conformational Restriction Blocks Glutamate Receptor Desensitization. Nat. Struct. Mol. Biol. 2006, 13, 1120-1127, 10.1038/nsmb1178
Armstrong, N.; Jasti, J.; Beich-Frandsen, M.; Gouaux, E. Measurement of Conformational Changes accompanying Desensitization in an Ionotropic Glutamate Receptor. Cell 2006, 127, 85-97, 10.1016/j.cell.2006.08.037
Pøhlsgaard, J.; Frydenvang, K.; Madsen, U.; Kastrup, J. S. Lessons from more than 80 Structures of the GluA2 Ligand-Binding Domain in Complex with Agonists, Antagonists and Allosteric Modulators. Neuropharmacology 2011, 60, 135-150, 10.1016/j.neuropharm.2010.08.004
Topliss, J. G.; Sherlock, M. H.; Leroy, H. R.; Konzelman, L. M.; Shapiro, E. P.; Pettersen, B. W.; Schneider, H.; Sperber, N. Antihypertensive agents. I. Nondiuretic 2 H-1,2,4-benzothiadiazine 1,1-dioxides. J. Med. Chem. 1963, 6, 122-127, 10.1021/jm00338a008
Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking. J. Mol. Biol. 1997, 267, 727-748, 10.1006/jmbi.1996.0897
Sakkiah, S.; Arooj, M.; Kumar, M. R.; Eom, S. H.; Lee, K. W. Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations. PLoS One 2013, 8, e51429, 10.1371/journal.pone.0051429
Tirado-Rives, J.; Jorgensen, W. L. Contribution of Conformer Focusing to the Uncertainty in Predicting Free Energies for Protein-ligand Binding. J. Med. Chem. 2006, 49, 5880-5884, 10.1021/jm060763i
Krintel, C.; Frydenvang, K.; Ceravalls de Rabassa, A.; Kaern, A. M.; Gajhede, M.; Pickering, D. S.; Kastrup, J. S. L-Asp is a Useful Tool in the Purification of the Ionotropic Glutamate Receptor A2 Ligand-Binding Domain. FEBS J. 2014, 281, 2422-2430, 10.1111/febs.12795
Evans, P. R. An Introduction to Data Reduction: Space-Group Determination, Scaling and Intensity Statistics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 282-292, 10.1107/S090744491003982X
Winn, M. D.; Ballard, C. C.; Cowtan, K. D.; Dodson, E. J.; Emsley, P.; Evans, P. R.; Keegan, R. M.; Krissinel, E. B.; Leslie, A. G.; McCoy, A.; McNicholas, S. J.; Murshudov, G. N.; Pannu, N. S.; Potterton, E. A.; Powell, H. R.; Read, R. J.; Vagin, A.; Wilson, K. S. Overview of the CCP4 Suite and Current Developments. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 235-242, 10.1107/S0907444910045749
McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser Crystallographic Software. J. Appl. Crystallogr. 2007, 40, 658-674, 10.1107/S0021889807021206
Terwilliger, T. C.; Grosse-Kunstleve, R. W.; Afonine, P. V.; Moriarty, N. W.; Zwart, P. H.; Hung, L.-W.; Read, R. J.; Adams, P. D. Iterative Model Building, Structure Refinement and Density Modification with the PHENIX AutoBuild Wizard. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2008, D64, 61-69, 10.1107/S090744490705024X
Adams, P. D.; Afonine, P. V.; Bunkóczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L. W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. PHENIX: a Comprehensive Python-Based System for Macromolecular Structure Solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221, 10.1107/S0907444909052925
Moriarty, N. W.; Grosse-Kunstleve, R. W.; Adams, P. D. Electronic Ligand Builder and Optimization Workbench (eLBOW): a Tool for Ligand Coordinate and Restraint Generation. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2009, 65, 1074-1080, 10.1107/S0907444909029436
Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K. Features and Development of Coot. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 486-501, 10.1107/S0907444910007493
Davis, I. W.; Leaver-Fay, A.; Chen, V. B.; Block, J. N.; Kapral, G. J.; Wang, X.; Murray, L. W.; Arendall, W. B.; Snoeyink, J.; Richardson, J. S.; Richardson, D. C. MolProbity: All-Atom Contacts and Structure Validation for Proteins and Nucleic Acids. Nucleic Acids Res. 2007, 35, W375-W383, 10.1093/nar/gkm216
Hayward, S.; Berendsen, H. J. C. Systematic Analysis of Domain Motions in Proteins from Conformational Change; New Results on Citrate Synthase and T4 Lysozyme. Proteins: Struct., Funct., Genet. 1998, 30, 144-154, 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N
Battisti, U. M.; Jozwiak, K.; Cannazza, G.; Puia, G.; Stocca, G.; Braghiroli, D.; Parenti, C.; Brasili, L.; Carrozzo, M. M.; Citti, C.; Troisi, L. 5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors. ACS Med. Chem. Lett. 2012, 3, 25-29, 10.1021/ml200184w
Halgren, T. A. Merck Molecular Force Field. I. Basis, Form, Scope, Parameterization, and Performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519, 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
